Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Sobin BA, et al. Mithramycins as transplanted tumor inhibiting agents. US Patent 3,646,194 dated Feb 29 1972
Nucleotide (GenBank) : Y10907 S.argillaceus mtmD and mtmE genes.
Nucleotide (GenBank) : AJ007932 Streptomyces argillaceus mithramycin biosynthetic genes.
Nucleotide (GenBank) : X89899 S.argillaceus DNA for mtmQ, mtmX, mtmP, mtmK, mtmS and mtmT1 genes.
Nucleotide (GenBank) : AF056309 Streptomyces argillaceus membrane protein and mithramycin regulator MtmR (mtmR) genes, complete cds.
Nucleotide (GenBank) : AF056310 Streptomyces argillaceus sequence similar to the region upstream of the mithramycin regulatory gene.
Nucleotide (GenBank) : U43537 Streptomyces argillaceus mithramycin resistance determinant, ATP-binding protein (mtrA) and membrane protein (mtrB) genes, complete cds.
